The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amlodipine/Valsartan Rowex 10 mg/160 mg Film-coated tablets

Rowex LtdPA0711/253/003

Main Information

Trade NameAmlodipine/Valsartan Rowex 10 mg/160 mg Film-coated tablets
Active SubstancesAmlodipine
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/253/003

Group Information

ATC CodeC09DB Angiotensin II antagonists and calcium channel blockers
C09DB01 valsartan and amlodipine


License statusWithdrawn
Withdrawn Date13/07/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0042-084-003
Interchangeable List DocumentPDF of Interchangeable List
« Back